Pharmaceutical Industry Information Portal

HomeNews

News

Russia approves AstraZeneca’s drug for coronavirus prophylaxis

The Russian Ministry of Health approved circulation of Evusheld, a COVID-19 prophylaxis drug by AstraZeneca, on the territory of the country, according to the...

FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant

The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research. As we have throughout the COVID-19 pandemic,...

The Skolkovo Innovation Center has completed Phase I of a clinical trial for stomach cancer treatment

Alofanib helped to stop the development of the disease in 70% of patients. Such data were obtained during a clinical trial of an innovative...

St. Petersburg-based research institute files application for registering its COVID-19 vaccine – State Register

The St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical-Biological Agency (FMBA) has filed an application with the Health Ministry...

Russian drug Longidaza® to help cope with post-Covid is patented in India

Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which already has patents in a...

Brightway Group pharmaceutical plant will be opened in CEZ Technopolis Moscow

The resident of SEZ Technopolis Moscow plans to complete the construction of a new large pharmaceutical production at Alabushevo site this year. The enterprise...
spot_img

Expert Articles

spot_img